| .beta.-(3, 4-Dihydroxyphenyl)alanine |
| .beta.-(3,4-Dihydroxyphenyl)-L-alanine |
| .beta.-(3,4-Dihydroxyphenyl)alanine |
| (-)-(3,4-Dihydroxyphenyl)alanine |
| (-)-3-(3,4-Dihydroxyphenyl)-L-alanine |
| (-)-Dopa |
| (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate |
| (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid |
| (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acidL-dopa |
| (S)-2-Amino-3-(3,4-dihydroxy-phenyl)-propionic acid |
| (S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid |
| (S)-3,4-dihydroxyphenylalanine |
| 13173-EP2269989A1 |
| 13173-EP2277876A1 |
| 13173-EP2277882A1 |
| 13173-EP2281559A1 |
| 13173-EP2281815A1 |
| 13173-EP2292614A1 |
| 13173-EP2295412A1 |
| 13173-EP2295413A1 |
| 13173-EP2295439A1 |
| 13173-EP2298731A1 |
| 13173-EP2301933A1 |
| 13173-EP2301934A1 |
| 13173-EP2305633A1 |
| 13173-EP2305640A2 |
| 13173-EP2308867A2 |
| 13173-EP2308870A2 |
| 13173-EP2311827A1 |
| 13173-EP2311837A1 |
| 13173-EP2314571A2 |
| 13173-EP2316470A2 |
| 13173-EP2316834A1 |
| 1E83F927-C221-46AA-B90A-81B33C5F3868 |
| 21660-EP2272832A1 |
| 21660-EP2275420A1 |
| 21660-EP2281559A1 |
| 21660-EP2301934A1 |
| 21660-EP2314571A2 |
| 21920-EP2295410A1 |
| 21920-EP2301939A1 |
| 21920-EP2314571A2 |
| 23734-74-9 |
| 25525-15-9 |
| 3-(3,4-Dihydroxyphenyl)-L-alanine |
| 3-(3,4-Dihydroxyphenyl)-L-alanine, 99% |
| 3-(3,4-Dihydroxyphenyl)-L-alanine; L-3-Hydroxytyrosine; L-DOPA; Levodopa |
| 3-Hydroxy-L-tyrosine |
| 3, 4-Dihydroxy-L-phenylalanine |
| 3, 4-Dihydroxyphenylalanine |
| 3,4-dihydroxy-L-phenylalanine |
| 3,4-Dihydroxy-L-phenylalanine, >=98% (TLC) |
| 3,4-Dihydroxy-L-phenylalanine, certified reference material, TraceCERT(R) |
| 3,4-Dihydroxy-L-phenylalanine, Vetec(TM) reagent grade, 98% |
| 3,4-Dihydroxyphenyl-L-alanine |
| 3,4-Dihydroxyphenylalanine |
| 3,4-Dihydroxyphenylalanine (VAN) |
| 34241-25-3 |
| 46627O600J |
| 587-45-1 |
| 59-92-7 |
| 59L927 |
| 72572-99-7 |
| 72573-00-3 |
| 88250-23-1 |
| 90638-38-3 |
| AB00052418_08 |
| AB00052418_09 |
| AB00052418-06 |
| AB00052418-07 |
| AB0013279 |
| AB1009504 |
| AC-8432 |
| AC1L1LOR |
| AC1Q4U7F |
| AJ-24154 |
| AK187821 |
| AKOS010396267 |
| Alanine, 3-(3, 4-dihydroxyphenyl)-, (-)- |
| Alanine, 3-(3,4-dihydroxyphenyl)- |
| Alanine, 3-(3,4-dihydroxyphenyl)-, (-)- |
| alanine, 3-(3,4-dihydroxyphenyl)-, L- |
| Alanine,4-dihydroxyphenyl)- |
| Alanine,4-dihydroxyphenyl)-, (-)- |
| Alanine,4-dihydroxyphenyl)-, L- |
| AM82124 |
| AN-1108 |
| ANW-33396 |
| AS-13287 |
| b-(3,4-Dihydroxyphenyl)-a-L-alanine |
| b-(3,4-Dihydroxyphenyl)-L-alanine |
| b-(3,4-Dihydroxyphenyl)alanine |
| BC677906 |
| BDBM50130192 |
| BDBM60928 |
| Bendopa |
| beta-(3,4-Dihydroxyphenyl)-alpha-alanine |
| beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine |
| beta-(3,4-Dihydroxyphenyl)-L-alanine |
| beta-(3,4-Dihydroxyphenyl)alanine |
| BIDD:GT0158 |
| Biodopa |
| bmse000322 |
| BP-12850 |
| BPBio1_000059 |
| Brocadopa |
| BSPBio_000053 |
| BSPBio_002354 |
| C00355 |
| C9H11NO4 |
| CAS-59-92-7 |
| CCG-39571 |
| CCRIS 3766 |
| Cerepap |
| CHEBI:15765 |
| CHEMBL1009 |
| Cidandopa |
| component of Sinemet |
| CS-1945 |
| CTK1H2187 |
| CVT-301 |
| D 9628 |
| D00059 |
| D0600 |
| D9628 |
| DB01235 |
| Deadopa |
| Dihydroxy-L-phenylalanine |
| dihydroxyphenylalanine |
| DivK1c_000452 |
| Dopa |
| Dopaflex |
| Dopaidan |
| Dopal-fher |
| Dopalina |
| Dopar |
| Dopar (TN) |
| Doparkine |
| Doparl |
| Dopasol |
| Dopaston |
| Dopaston SE |
| Dopastone |
| Dopastral |
| Dopicar |
| Doprin |
| DSSTox_CID_3209 |
| DSSTox_GSID_23209 |
| DSSTox_RID_76926 |
| DTXSID9023209 |
| EINECS 200-445-2 |
| Eldopal |
| Eldopar |
| Eldopatec |
| Epitope ID:150927 |
| EU-0100454 |
| Eurodopa |
| F0347-4695 |
| FT-0603250 |
| GTPL3639 |
| H813 |
| Helfo DOPA |
| Helfo-Dopa |
| HMS1568C15 |
| HMS1922J14 |
| HMS2090O08 |
| HMS2093N04 |
| HMS2095C15 |
| HMS2230B04 |
| HMS3261K10 |
| HMS3712C15 |
| HMS501G14 |
| HSDB 3348 |
| HY-N0304 |
| I01-10387 |
| IDI1_000452 |
| Inbrija (levodopa inhalation powder) |
| Insulamina |
| IV Levodopa |
| J10404 |
| KBio1_000452 |
| KBio2_000934 |
| KBio2_003502 |
| KBio2_006070 |
| KBioGR_001177 |
| KBioSS_000934 |
| KM0355 |
| L Dopa |
| L-.beta.-(3,4-Dihydroxyphenyl)alanine |
| L-(-)-Dopa |
| L-(3, 4-Dihydroxyphenyl)-.alpha.-alanine |
| L-(3, 4-Dihydroxyphenyl)alanine |
| L-(3,4-Dihydroxyphenyl)-.alpha.-alanine |
| L-(3,4-Dihydroxyphenyl)alanine |
| L-(o-Dihydroxyphenyl)alanine |
| L-3-(3,4-dihydroxy-phenyl)alanine |
| L-3-(3,4-dihydroxyphenyl)-Alanine |
| L-3-(3,4-Dihydroxyphenyl)alanine |
| L-3-(3,4-Dihydroxyphenyl)alanine（L-DOPA ） |
| L-3-Hydroxytyrosine |
| L-3,4-Dihydrophenylalanine |
| L-3,4-Dihydroxyphenylalanine |
| L-4-5-Dihydroxyphenylalanine |
| L-b-(3,4-Dihydroxyphenyl)-a-alanine |
| L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine |
| L-beta-(3,4-Dihydroxyphenyl)alanine |
| L-Dihydroxyphenylalanine |
| L-dopa |
| L-Dopa, L-3-Hydroxytyrosine |
| L-DOPA; Levodopa |
| L-O-Dihydroxyphenylalanine |
| L-o-Hydroxytyrosine |
| L-Tyrosine, 3-hydroxy- |
| L(-)-Dopa |
| Laradopa |
| Larodopa |
| Ledopa |
| Levedopa |
| levodopa |
| Levodopa (JP15/USP) |
| Levodopa (JP17/USP/INN) |
| Levodopa (Sinemet) |
| Levodopa [USAN:INN:BAN:JAN] |
| Levodopa [USAN:USP:INN:BAN:JAN] |
| Levodopa, British Pharmacopoeia (BP) Reference Standard |
| Levodopa, European Pharmacopoeia (EP) Reference Standard |
| Levodopa, Pharmaceutical Secondary Standard; Certified Reference Material |
| Levodopa, United States Pharmacopeia (USP) Reference Standard |
| Levodopum |
| Levodopum [INN-Latin] |
| Levopa |
| Lopac-D-9628 |
| Lopac0_000454 |
| LP00454 |
| LS-255 |
| Madopa (Salt/Mix) |
| Maipedopa |
| MCULE-4743781842 |
| MFCD00002598 |
| MLS000028514 |
| MolPort-000-856-937 |
| N1648 |
| NCGC00015384-01 |
| NCGC00016270-01 |
| NCGC00016270-04 |
| NCGC00016270-06 |
| NCGC00016270-07 |
| NCGC00016270-09 |
| NCGC00016270-10 |
| NCGC00093869-04 |
| NCGC00261139-01 |
| NINDS_000452 |
| NSC 118381 |
| NSC-118381 |
| NSC-759573 |
| NSC118381 |
| NSC759573 |
| Parda |
| Pardopa |
| PDSP1_001541 |
| PDSP2_001525 |
| Pharmakon1600-02300205 |
| Prestwick_185 |
| Prestwick0_000017 |
| Prestwick1_000017 |
| Prestwick2_000017 |
| Prestwick3_000017 |
| Prodopa |
| Prolopa |
| Q-201294 |
| Ro 4-6316 |
| RTR-020755 |
| s1726 |
| SBB017533 |
| SBI-0050439.P003 |
| SC-10704 |
| SCHEMBL22655 |
| SDCCGMLS-0066924.P001 |
| SMR000058312 |
| Sobiodopa |
| SPBio_000391 |
| SPBio_001974 |
| Spectrum_000454 |
| Spectrum2_000496 |
| SPECTRUM2300205 |
| Spectrum4_000539 |
| Spectrum5_001899 |
| SR-01000075384 |
| SR-01000075384-1 |
| SR-01000075384-4 |
| SR-01000075384-6 |
| SR-01000075384-7 |
| ST086623 |
| Syndopa |
| Tox21_110338 |
| Tox21_500454 |
| TR-020755 |
| Tyrosine, 3-hydroxy- |
| UNII-46627O600J |
| UNII-QI9C343R60 component WTDRDQBEARUVNC-LURJTMIESA-N |
| VA11170 |
| Veldopa |
| Weldopa |
| WLN: QVYZ1R CQ DQ |
| WLN: QVYZ1R CQ DQ -L |
| WTDRDQBEARUVNC-LURJTMIESA-N |
| Z1762772338 |
| ZINC895199 |
